Coated Materials, Biocompatible

"Coated Materials, Biocompatible" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Biocompatible materials usually used in dental and bone implants that enhance biologic fixation, thereby increasing the bond strength between the coated material and bone, and minimize possible biological effects that may result from the implant itself.

Descriptor ID	D020099
MeSH Number(s)	D25.130.420 J01.637.051.130.420
Concept/Terms	Coated Materials, Biocompatible Coated Materials, Biocompatible Biocompatible Coated Materials Materials, Biocompatible Coated Surface-Coated Materials Materials, Surface-Coated Surface Coated Materials

Below are MeSH descriptors whose meaning is more general than "Coated Materials, Biocompatible".

Chemicals and Drugs [D]
Biomedical and Dental Materials [D25]
Biocompatible Materials [D25.130]
Coated Materials, Biocompatible [D25.130.420]
Technology, Industry, Agriculture [J]
Technology, Industry, and Agriculture [J01]
Manufactured Materials [J01.637]
Biomedical and Dental Materials [J01.637.051]
Biocompatible Materials [J01.637.051.130]
Coated Materials, Biocompatible [J01.637.051.130.420]

Below are MeSH descriptors whose meaning is related to "Coated Materials, Biocompatible".

Below are MeSH descriptors whose meaning is more specific than "Coated Materials, Biocompatible".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Coated Materials, Biocompatible" by people in this website by year, and whether "Coated Materials, Biocompatible" was a major or minor topic of these publications.

Bar chart showing 62 publications over 23 distinct years, with a maximum of 5 publications in 2007 and 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	3	0	3
2002	3	1	4
2003	2	1	3
2004	2	2	4
2005	3	0	3
2007	2	3	5
2008	5	0	5
2009	1	2	3
2010	1	1	2
2011	2	0	2
2012	1	2	3
2013	0	1	1
2014	3	0	3
2015	1	2	3
2016	0	2	2
2017	1	0	1
2018	2	1	3
2019	2	0	2
2020	1	0	1
2021	0	2	2
2022	0	3	3
2023	0	2	2
2024	2	0	2

Below are the most recent publications written about "Coated Materials, Biocompatible" by people in Profiles.

Brodmann M, Gray WA, Schneider PA, Kurzmann-Guetl K, Schweiger L, Zeller T, Thieme M, Kilaru S, Bachinsky WB, Feldman RL, Holden A, Varcoe RL, Lansky AJ, Rosenfield K. Editor's Choice - Results of SurVeil Versus IN.PACT Admiral Paclitaxel Coated Balloons in Femoropopliteal Arteries: 24 Month Outcomes of the Randomised TRANSCEND Study. Eur J Vasc Endovasc Surg. 2025 Mar; 69(3):452-462.

View in: PubMed
Basgul C, MacDonald DW, Klein GR, Piuzzi NS, Kurtz SM. Retrieval Analysis of Titanium Nitride Coatings for Orthopaedic Implants. J Arthroplasty. 2024 09; 39(9 Suppl 1):S272-S279.

View in: PubMed
Parikh SA, Schneider PA, Mullin CM, Rogers T, Gray WA. Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis. Lancet. 2023 11 18; 402(10415):1848-1856.

View in: PubMed
Merinopoulos I, Gunawardena T, Corballis N, Bhalraam U, Reinhold J, Wickramarachchi U, Maart C, Gilbert T, Richardson P, Sulfi S, Sarev T, Sawh C, Wistow T, Ryding A, Mohamed MO, Perperoglou A, Mamas MA, Vassiliou VS, Eccleshall SC. Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI. JACC Cardiovasc Interv. 2023 04 10; 16(7):771-779.

View in: PubMed
Merinopoulos I, Gunawardena T, Corballis N, Bhalraam U, Gilbert T, Maart C, Richardson P, Ryding A, Sarev T, Sawh C, Sulfi S, Wickramarachchi U, Wistow T, Mohamed MO, Mamas MA, Vassiliou VS, Eccleshall SC. Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice. Clin Res Cardiol. 2023 Sep; 112(9):1186-1193.

View in: PubMed
Aru RG, Tyagi SC. Endovascular treatment of femoropopliteal arterial occlusive disease: Current techniques and limitations. Semin Vasc Surg. 2022 Jun; 35(2):180-189.

View in: PubMed
Ullah W, Zghouzi M, Sattar Z, Ahmad B, Zahid S, Suleiman AM, Sattar Y, Khan MZ, Paul T, Bagur R, Qureshi MI, Fischman DL, Banerjee S, Prasad A, Alraies MC. Safety and efficacy of drug-coated balloon for peripheral artery revascularization-A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2022 03; 99(4):1319-1326.

View in: PubMed
Roy-Chaudhury P, Saad TF, Trerotola S. Drug-coated balloons and dialysis vascular access: is there light at the end of the tunnel . . . Kidney Int. 2021 08; 100(2):278-280.

View in: PubMed
Tepe G, Brodmann M, Werner M, Bachinsky W, Holden A, Zeller T, Mangalmurti S, Nolte-Ernsting C, Bertolet B, Scheinert D, Gray WA. Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial. JACC Cardiovasc Interv. 2021 06 28; 14(12):1352-1361.

View in: PubMed
Yerasi C, Case BC, Forrestal BJ, Kolm P, Dan K, Torguson R, Weintraub WS, Garcia-Garcia HM, Waksman R. Risk of Mortality with Paclitaxel Drug-Coated Balloon in De Novo Coronary Artery Disease. Cardiovasc Revasc Med. 2020 04; 21(4):549-555.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement